Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TAKEDA PHARMACEUTICAL COMPANY LIMITED

(4502)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about TAKEDA PHARMACEUTICAL COMPANY LIMITED
09/16TAKEDA PHARMACEUTICAL : Continues to Advance Growth Strategy with Sale Of Non-Co..
PU
09/16TAKEDA PHARMACEUTICAL : EXKIVITY (mobocertinib) Approved by U.S. FDA as the Firs..
AQ
09/15TAKEDA PHARMACEUTICAL : U.S. FDA approves Takeda's lung cancer therapy
RE
09/15TAKEDA PHARMACEUTICAL : U.S. FDA approves Takeda's lung cancer therapy
RE
09/15TAKEDA PHARMACEUTICAL : Exkivity Wins FDA Approval for Treatment of Lung Cancer ..
MT
09/15TAKEDA PHARMACEUTICAL : EXKIVITY™ (mobocertinib) Approved by U.S. FDA as t..
BU
09/15Food and Drug Administration Approves Takeda’s EXKIVITYÖ (Mobocertinib) for t..
CI
09/13TAKEDA PHARMACEUTICAL : Novavax Statement on Takeda Agreement to Provide 150 Mil..
AQ
09/07TAKEDA PHARMACEUTICAL : Response to the New Incident Announced by the Japanese M..
PU
09/07TAKEDA PHARMACEUTICAL : to Manufacture and Provide 150 Million Doses of Novavax'..
PU
09/07Takeda’s Responds to the New Incident Announced by the Japanese Ministry of H..
CI
09/06TAKEDA PHARMACEUTICAL : Japan to purchase 150 million doses of Takeda-produced N..
RE
09/06TAKEDA PHARMACEUTICAL : to Manufacture and Provide 150 Million Doses of Novavax'..
PU
09/06GENERAL ANNOUNCEMENT : :Takeda Response to the New Incident Announced by the Jap..
PU
09/06TAKEDA PHARMACEUTICAL : to Manufacture and Provide 150 Million Doses of Novavax'..
PU
More most relevant news
All news about TAKEDA PHARMACEUTICAL COMPANY LIMITED
09/16TAKEDA PHARMACEUTICAL : Continues to Advance Growth Strategy with Sale Of Non-Co..
PU
09/16TAKEDA PHARMACEUTICAL : EXKIVITY (mobocertinib) Approved by U.S. FDA as the Firs..
AQ
09/16THERMO FISHER SCIENTIFIC : FDA Approves Tissue-Based NGS Companion Diagnostic fo..
AQ
09/15TAKEDA PHARMACEUTICAL : U.S. FDA approves Takeda's lung cancer therapy
RE
09/15TAKEDA PHARMACEUTICAL : U.S. FDA approves Takeda's lung cancer therapy
RE
09/15TAKEDA PHARMACEUTICAL : Exkivity Wins FDA Approval for Treatment of Lung Cancer ..
MT
09/15TAKEDA PHARMACEUTICAL : EXKIVITY™ (mobocertinib) Approved by U.S. FDA as t..
BU
09/15Food and Drug Administration Approves Takeda’s EXKIVITYÖ (Mobocertinib) for t..
CI
09/13Takeda eyes vaccine business growth as dengue, COVID-19 shots progress - CEO
RE
09/13TAKEDA PHARMACEUTICAL : Novavax Statement on Takeda Agreement to Provide 150 Mil..
AQ
More news
News in other languages on TAKEDA PHARMACEUTICAL COMPANY LIMITED
09/16TAKEDA PHARMACEUTICAL : EXKIVITY™ (Mobocertinib) von Takeda erhält als ers..
09/16TAKEDA PHARMACEUTICAL : EXKIVITY™ (mobocertinib) de Takeda fue aprobado po..
09/16TAKEDA PHARMACEUTICAL : EXKIVITY™ (mobocertinib) de Takeda a été approuvé ..
09/15Exkivity de Takeda est approuvé par la FDA pour le traitement du cancer du po..
09/13Takeda envisage la croissance de ses activités dans le domaine des vaccins gr..
09/07Tokyo encore soutenue par les attentes de changement au sommet de l'Etat
09/06Le Japon va acheter 150 millions de doses de vaccins Novavax produits par Tak..
09/02TAKEDA PHARMACEUTICAL : fait le point sur l'essai PANTHER (Pevonedistat-3001) de..
09/02Tokyo dans le vert avant l'emploi américain
09/02TAKEDA PHARMACEUTICAL : brinda nueva información sobre su ensayo PANTHER (Pevone..
More news
Analyst Recommendations on TAKEDA PHARMACEUTICAL COMPANY LIMITED
2020TAKEDA PHARMACEUTICAL : Japan's Takeda says drug pipeline to lift sales to $48 b..
RE
2018Takeda clears key hurdle as investors back $59 billion Shire deal
RE
2018Takeda investors back $59 billion Shire deal, but wary of debt load
RE
2018Takeda shareholders bin proposal from anti-Shire group; only 10 percent in fa..
RE
2018Takeda shareholders bin proposal from anti-Shire group; only 10 percent in fa..
RE
More recommendations
Press releases
09/16TAKEDA PHARMACEUTICAL : Continues to Advance Growth Strategy with Sale Of Non-Co..
PU
09/16TAKEDA PHARMACEUTICAL : EXKIVITY (mobocertinib) Approved by U.S. FDA as the Firs..
AQ
09/16THERMO FISHER SCIENTIFIC : FDA Approves Tissue-Based NGS Companion Diagnostic fo..
AQ
09/15TAKEDA PHARMACEUTICAL : EXKIVITY™ (mobocertinib) Approved by U.S. FDA as t..
BU
09/13TAKEDA PHARMACEUTICAL : Novavax Statement on Takeda Agreement to Provide 150 Mil..
AQ
More press releases
Upcoming event on TAKEDA PHARMACEUTICAL COMPANY LIMITED
09/29/21